Zura Bio (ZURA) Earnings Date & Reports

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ZURA is expected to report earnings to fall 23.86% to -16 cents per share on August 19

Q2'26

Est.

$-0.17

Q1'26

Missed

by $0.03

Q4'25

Missed

by $0.19

Q3'25

Beat

by $0.14

Q2'25

Beat

by $0.13

The last earnings report on May 07 showed earnings per share of -21 cents, missing the estimate of -18 cents. With 324.68K shares outstanding, the current market capitalization sits at 401.35M.

View a ticker or compare two or three

Compare

ZURA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ZURA